1. Home
  2. OBIO vs QH Comparison

OBIO vs QH Comparison

Compare OBIO & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • QH
  • Stock Information
  • Founded
  • OBIO 2017
  • QH 2012
  • Country
  • OBIO United States
  • QH China
  • Employees
  • OBIO N/A
  • QH N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • QH Business Services
  • Sector
  • OBIO Health Care
  • QH Consumer Discretionary
  • Exchange
  • OBIO Nasdaq
  • QH Nasdaq
  • Market Cap
  • OBIO 118.8M
  • QH 115.7M
  • IPO Year
  • OBIO N/A
  • QH 2020
  • Fundamental
  • Price
  • OBIO $3.29
  • QH $1.35
  • Analyst Decision
  • OBIO Strong Buy
  • QH
  • Analyst Count
  • OBIO 5
  • QH 0
  • Target Price
  • OBIO $14.20
  • QH N/A
  • AVG Volume (30 Days)
  • OBIO 303.1K
  • QH 476.1K
  • Earning Date
  • OBIO 08-11-2025
  • QH 08-27-2025
  • Dividend Yield
  • OBIO N/A
  • QH N/A
  • EPS Growth
  • OBIO N/A
  • QH N/A
  • EPS
  • OBIO N/A
  • QH 0.01
  • Revenue
  • OBIO $2,886,000.00
  • QH $417,431,053.00
  • Revenue This Year
  • OBIO $20.47
  • QH N/A
  • Revenue Next Year
  • OBIO $11.45
  • QH N/A
  • P/E Ratio
  • OBIO N/A
  • QH $151.55
  • Revenue Growth
  • OBIO 30.23
  • QH N/A
  • 52 Week Low
  • OBIO $2.37
  • QH $0.25
  • 52 Week High
  • OBIO $8.30
  • QH $2.27
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 60.31
  • QH 48.99
  • Support Level
  • OBIO $3.05
  • QH $1.36
  • Resistance Level
  • OBIO $3.24
  • QH $1.76
  • Average True Range (ATR)
  • OBIO 0.16
  • QH 0.18
  • MACD
  • OBIO 0.03
  • QH 0.01
  • Stochastic Oscillator
  • OBIO 93.75
  • QH 22.09

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.

Share on Social Networks: